pharma · Inflammatory Bowel Disease (IBD) · Melanoma · IRON
Disc Medicine
Disc Medicine patent portfolio — 6 USPTO pharmaceutical patents (A61K/A61P) with grant dates, status, and loss-of-exclusivity filters.
Company details
- Status
- Public
- HQ
- 321 Arsenal St., Suite 101, Watertown, Massachusetts 02472-5710, US
- Employees
- 165
- Programs
- 3
- Drugs
- 357
- Patents
- 6
Disc Medicine patents
6 pharmaceutical patents indexed for Disc Medicine. 0 expire within 24 months.
Disc Medicine has 6 pharmaceutical patents in our USPTO PatentsView index (A61K/A61P). 0 expire within 24 months — use filters for patent-cliff planning.
Patent portfolio
-
US 11285184
Cannabidiol alkaline composition
granted -
US 10973758
Methods of eye treatment using therapeutic compositions containing dipyridamole
granted -
US 10357453
Methods of eye treatment using therapeutic compositions containing dipyridamole
granted -
US 10322129
Therapeutic compositions containing dipyridamole, treatment packs and kits including such compositions and methods for producing same
granted -
US 10226420
Methods of eye treatment using therapeutic compositions containing dipyridamole
granted -
US 9901580
Methods of eye treatment using therapeutic compositions containing dipyridamole
granted
Frequently asked questions
How many patents does Disc Medicine have?
6 published patents match the current filter (all indexed). The full portfolio is indexed from USPTO PatentsView (A61K/A61P).
When do Disc Medicine patents expire?
0 patents in the full portfolio expire within 24 months. Use the expiring filters above or open individual patent pages for grant and expiration dates.